Dr. Gohil is a board-certified UCI Health specialist in infectious diseases who serves as associate medical director for Epidemiology and Infection Prevention.
She earned her medical degree from Tufts University School of Medicine in Boston, Mass. She completed an internal medicine residency at the UC Davis School of Medicine, followed by a clinical and research fellowship in infectious diseases at the Albert Einstein School of Medicine in New York City.
Gohil’s research focuses on infection prevention and antibiotic stewardship. She has led several large-scale epidemiologic studies to evaluate patients' risk for sepsis and hospital readmissions. She created a novel scoring system to identify high-risk patients and prevent central line associated bloodstream infections (CLABSIs) in various healthcare settings. She is also the lead investigator of four large randomized controlled trials to develop a “precision medicine” approach to empiric antibiotic selection.
In her current administrative role, Gohil leads the UCI Health response to the novel coronavirus pandemic, including the clinical and epidemiologic assessment of healthcare providers and patients, COVID-19 testing, exposure definition and response, contact tracing, vaccination and infection prevention strategies to limit viral spread.